ZA881067B - Production of proteins in active forms - Google Patents

Production of proteins in active forms

Info

Publication number
ZA881067B
ZA881067B ZA881067A ZA881067A ZA881067B ZA 881067 B ZA881067 B ZA 881067B ZA 881067 A ZA881067 A ZA 881067A ZA 881067 A ZA881067 A ZA 881067A ZA 881067 B ZA881067 B ZA 881067B
Authority
ZA
South Africa
Prior art keywords
protein
proteins
production
rupturing
active forms
Prior art date
Application number
ZA881067A
Other languages
English (en)
Inventor
John Patroni Joseph
Original Assignee
Bunge (Australia) Pty. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bunge (Australia) Pty. Ltd. filed Critical Bunge (Australia) Pty. Ltd.
Publication of ZA881067B publication Critical patent/ZA881067B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
ZA881067A 1987-02-20 1988-02-16 Production of proteins in active forms ZA881067B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPI046287 1987-02-20

Publications (1)

Publication Number Publication Date
ZA881067B true ZA881067B (en) 1988-08-11

Family

ID=3772028

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881067A ZA881067B (en) 1987-02-20 1988-02-16 Production of proteins in active forms

Country Status (10)

Country Link
US (1) US4966963A (de)
EP (1) EP0279619B1 (de)
JP (1) JPS63264598A (de)
AT (1) ATE114319T1 (de)
AU (1) AU612133B2 (de)
CA (1) CA1326106C (de)
DE (1) DE3852140T2 (de)
ES (1) ES2065906T3 (de)
NZ (1) NZ223559A (de)
ZA (1) ZA881067B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU609824B2 (en) * 1987-06-15 1991-05-09 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
EP0366684B1 (de) * 1987-06-26 1994-01-26 Commonwealth Scientific And Industrial Research Organisation Durch virusneutralisierende und schützende monokonale antikörper erkanntes ibdv vp2 epitop
US5136027A (en) * 1989-05-02 1992-08-04 Abbott Laboratories Method for renaturing proteins in the presence of alkyl sulfate detergents
US5101018A (en) * 1989-06-12 1992-03-31 International Minerals & Chemical Corp. Method for recovering recombinant proteins
ATE113060T1 (de) * 1989-12-05 1994-11-15 American Cyanamid Co Methode zur auflösung und naturation von somatotropin unter verwendung von einer niedrigen harnstoffkonzentration.
ES2119779T3 (es) * 1990-09-05 1998-10-16 Southern Cross Biotech Pty Ltd Solubilizacion de proteinas en formas activas.
US6566098B1 (en) * 1990-09-14 2003-05-20 The United States Of America As Represented By The Department Of Health And Human Services DNA encoding truncated hepatocyte growth factor variants
GB2281558B (en) * 1993-09-07 1997-02-19 Joseph Matthew Gaugas Supplying sulphur to plants
US5861372A (en) * 1996-02-22 1999-01-19 The Children's Medical Center Corporation Aggregate angiostatin and method of use
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US5840838A (en) * 1996-02-29 1998-11-24 University Of Kentucky Research Foundation Process for enhancing the activity of amyloid β peptides
US20030190307A1 (en) 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US6566583B1 (en) 1997-06-04 2003-05-20 Daniel Facciotti Schizochytrium PKS genes
CA2338665C (en) 1998-08-06 2011-01-18 Mountain View Pharmaceuticals, Inc. Peg-urate oxidase conjugates and use thereof
US20080159976A1 (en) * 2005-04-11 2008-07-03 Jacob Hartman Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
US8148123B2 (en) 2005-04-11 2012-04-03 Savient Pharmaceuticals, Inc. Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase
EP1871877A2 (de) 2005-04-11 2008-01-02 Savient Pharmaceuticals, Inc. Nebenform von uratoxidase und ihre verwendung
ES2856881T3 (es) 2005-04-11 2021-09-28 Horizon Pharma Rheumatology Llc Formas variantes de urato oxidasa y su uso
EP1883425A1 (de) * 2005-05-23 2008-02-06 Universite De Geneve Injizierbare superparamagnetische nanoteilchen zur behandlung von hyperthermie und verwendung zur bildung eines hyperthermischen implantats
ES2532804T3 (es) * 2006-04-12 2015-03-31 Crealta Pharmaceuticals Llc Purificación de proteínas con tensioactivo catiónico
US9388406B2 (en) 2008-11-17 2016-07-12 Cornell University System useful for reporting protein-protein interactions in the bacterial periplasm
AU2010265964B2 (en) 2009-06-25 2014-09-18 Horizon Therapeutics Usa, Inc. Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
GR79124B (de) * 1982-12-22 1984-10-02 Genentech Inc
ES8800957A1 (es) * 1985-02-22 1987-12-01 Monsanto Co Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina
US4731440A (en) * 1985-02-22 1988-03-15 Monsanto Company Method of somatotropin solubilization using dimethylsulfone and naturation
US4766224A (en) * 1985-08-19 1988-08-23 International Minerals & Chemical Corp. Purification and activation of proteins from insoluble inclusion bodies
AU597924B2 (en) * 1985-12-11 1990-06-14 Natinco Nv Solubilization of protein aggregates
AU612133B2 (en) * 1987-02-20 1991-07-04 Natinco Nv Production of proteins in active forms
AU607988B2 (en) * 1987-04-21 1991-03-21 Southern Cross Biotech Pty Ltd. Production of proteins in active forms
AU1763188A (en) * 1987-06-15 1988-12-15 Bunge (Australia) Pty Ltd Recovery of proteins in active form

Also Published As

Publication number Publication date
DE3852140T2 (de) 1995-04-06
JPS63264598A (ja) 1988-11-01
AU1141288A (en) 1988-08-25
ES2065906T3 (es) 1995-03-01
EP0279619B1 (de) 1994-11-23
AU612133B2 (en) 1991-07-04
EP0279619A3 (en) 1990-04-11
EP0279619A2 (de) 1988-08-24
DE3852140D1 (de) 1995-01-05
ATE114319T1 (de) 1994-12-15
US4966963A (en) 1990-10-30
NZ223559A (en) 1989-09-27
CA1326106C (en) 1994-01-11

Similar Documents

Publication Publication Date Title
EP0279619A3 (en) Production of proteins in active forms
CS274681B2 (en) Method of erythropoietin's stabilized preparation production
AU564405B2 (en) Production of stabilized whey protein product
FI914241A0 (fi) Vacciner foer icke-typade haemo philus influenzae-bakterier.
CA2069450A1 (fr) Procede de fabrication d'un materiau pour osteoplastie a partir d'un tissu osseux naturel et materiau obtenu par ce procede
GR3006727T3 (de)
GR3003536T3 (de)
GR3006807T3 (de)
EP0241022A3 (en) Process for the renaturation of proteins
MY103362A (en) Production of proteins in active forms
DE69129747D1 (de) In lösung bringen von proteinen in aktiver form
ES8900068A1 (es) Procedimiento de dosificacion de anticuerpos dirigidos contra toxinas bacterianas.
NZ235297A (en) Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution
EP0273450A3 (en) Solubilizer for water-insoluble alginates, aqueous solution thereof and dissolvig method using the aqueous solution
EP0274219A3 (de) Interleukin-2 enthaltende Liposan-Zusammensetzung und Methode zu ihrer Herstellung
KR960006258B1 (en) Process for the preparation of n,n-disubstituted ñô-amino acids and their use in water-proofing leather and skins
CS475988A1 (en) (3,7-dialkoxy-3,7-dialkyl-2-bromoctyl)-(4-chlorophenylether) as biologically efficient substance and method of its preparation